| Descriptor English: | Ramucirumab | ||||||
| Descriptor Spanish: |
Ramucirumab
| ||||||
| Descriptor Portuguese: | Ramucirumab | ||||||
| Descriptor French: | Without translation | ||||||
| Entry term(s): |
1121B Cyramza IMC 1121B IMC-1121B IMC1121B LY3009806 |
||||||
| Tree number(s): |
D12.776.124.486.485.114.224.060.866 D12.776.124.790.651.114.224.060.866 D12.776.377.715.548.114.224.200.866 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000096662 | ||||||
| Scope note: | A humanized monoclonal antibody and antagonist of VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 (VEGFR2). |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Angiogenesis Inhibitors |
||||||
| Registry Number: | D99YVK4L0X | ||||||
| Public MeSH Note: | 2024; RAMUCIRUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2009-2023 |
||||||
| History Note: | 2024 (2009) |
||||||
| DeCS ID: | 60500 | ||||||
| Unique ID: | D000096662 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2024/01/01 | ||||||
| Date of Entry: | 2023/07/26 | ||||||
| Revision Date: | 2023/05/17 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Ramucirumab
- Preferred
LY3009806
- Narrower
Cyramza
- Narrower
IMC 1121B
- Narrower
| Concept UI |
M000762505 |
| Scope note | A humanized monoclonal antibody and antagonist of VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 (VEGFR2). |
| Preferred term | Ramucirumab |
| Concept UI |
M000654744 |
| Preferred term | LY3009806 |
| Concept UI |
M000600995 |
| Preferred term | Cyramza |
| Concept UI |
M0538911 |
| Preferred term | IMC 1121B |
| Entry term(s) |
1121B IMC-1121B IMC1121B |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
